UK - Ashmore invests EUR 5.1m into AGOL
Listed investor group Ashmore Group plc has invested in excess of EUR 5m into its publically traded special situations-focused fund Ashmore Global Opportunities Limited (AGOL).
More on Industry
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Pantheon promotes four to partner
Petra Bukovec is a member of Pantheon's secondaries team and is based in London
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018